123 related articles for article (PubMed ID: 38858411)
1. Comparing two mucin secretagogues for the treatment of dry eye disease: a prospective randomized crossover trial.
Jin Y; Seo KY; Kim SW
Sci Rep; 2024 Jun; 14(1):13306. PubMed ID: 38858411
[TBL] [Abstract][Full Text] [Related]
2. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.
Shigeyasu C; Yamada M; Akune Y; Tsubota K
Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103
[TBL] [Abstract][Full Text] [Related]
3. Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
Yamane M; Ogawa Y; Fukui M; Kamoi M; Saijo-Ban Y; Yaguchi S; Mukai S; Kawakita T; Simmura S; Tsubota K
Optom Vis Sci; 2015 Apr; 92(4 Suppl 1):S25-32. PubMed ID: 25785527
[TBL] [Abstract][Full Text] [Related]
4. A Clinic-based Survey of Clinical Characteristics and Practice Pattern of Dry Eye in Japan.
Kawashima M; Yamada M; Suwaki K; Shigeyasu C; Uchino M; Hiratsuka Y; Yokoi N; Tsubota K;
Adv Ther; 2017 Mar; 34(3):732-743. PubMed ID: 28181147
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial.
Park CH; Lee HK; Kim MK; Kim EC; Kim JY; Kim TI; Kim HK; Song JS; Yoon KC; Lee DH; Chung TY; Choi CY; Kim HS
BMC Ophthalmol; 2019 Jun; 19(1):131. PubMed ID: 31208393
[TBL] [Abstract][Full Text] [Related]
6. The Efficacy of Diquafosol Ophthalmic Solution in Non-Sjögren and Sjögren Syndrome Dry Eye Patients Unresponsive to Artificial Tear.
Jeon HS; Hyon JY
J Ocul Pharmacol Ther; 2016 Sep; 32(7):463-8. PubMed ID: 27294831
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Topical Diquafosol Tetrasodium 3% on Dry Eye After Cataract Surgery.
Baek J; Doh SH; Chung SK
Curr Eye Res; 2016 Oct; 41(10):1281-1285. PubMed ID: 27049809
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of 1% and 2% rebamipide clear solution in dry eye disease: a multicenter randomized trial.
Eom Y; Chung SH; Chung TY; Kim JY; Choi CY; Yoon KC; Ko BY; Kim HK; Kim MK; Lee HK; Song JS; Hyon JY; Seo KY; Lee JS; Kim HM
BMC Ophthalmol; 2023 Aug; 23(1):343. PubMed ID: 37537533
[TBL] [Abstract][Full Text] [Related]
9. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
Kinoshita S; Oshiden K; Awamura S; Suzuki H; Nakamichi N; Yokoi N;
Ophthalmology; 2013 Jun; 120(6):1158-65. PubMed ID: 23490326
[TBL] [Abstract][Full Text] [Related]
10. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial.
Park DH; Chung JK; Seo DR; Lee SJ
Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Combined Tear Film Therapy in Patients with Evaporative Dry Eye with Short Tear Film Breakup Time.
Kim YH; Kang YS; Lee HS; Choi W; You IC; Yoon KC
J Ocul Pharmacol Ther; 2017 Oct; 33(8):635-643. PubMed ID: 28846481
[TBL] [Abstract][Full Text] [Related]
12. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.
Tauber J; Davitt WF; Bokosky JE; Nichols KK; Yerxa BR; Schaberg AE; LaVange LM; Mills-Wilson MC; Kellerman DJ
Cornea; 2004 Nov; 23(8):784-92. PubMed ID: 15502479
[TBL] [Abstract][Full Text] [Related]
13. Impact of Diquafosol Ophthalmic Solution on Tear Film and Dry Eye Symptom in Type 2 Diabetic Dry Eye: A Pilot Study.
Zhang Q; Zhang H; Qin G; Wu Y; Song Y; Yang L; Yu S; He X; Moore JE; Moutari S; Palme C; Xu L; He W; Pazo EE
J Ocul Pharmacol Ther; 2022 Mar; 38(2):133-140. PubMed ID: 35049373
[No Abstract] [Full Text] [Related]
14. Efficacy of Rebamipide Instillation for Contact Lens Discomfort With Dry Eye.
Igarashi T; Kobayashi M; Yaguchi C; Fujimoto C; Suzuki H; Takahashi H
Eye Contact Lens; 2018 Nov; 44 Suppl 2(2):S137-S142. PubMed ID: 29135738
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of the effect of diquafosol ophthalmic solution in glaucoma patients with dry eye syndrome.
Jin SW; Min JS
Jpn J Ophthalmol; 2016 May; 60(3):150-5. PubMed ID: 26873225
[TBL] [Abstract][Full Text] [Related]
16. Effects of Diquafosol Ophthalmic Solution on Quality of Life in Dry Eye Assessed Using the Dry Eye-Related Quality-of-Life Score Questionnaire: Effectiveness in Patients While Reading and Using Visual Display Terminals.
Utsunomiya T; Kawahara A; Hanada K; Yoshida A
Cornea; 2017 Aug; 36(8):908-914. PubMed ID: 28542084
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K;
Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease.
Mun Y; Kwon JW; Oh JY
BMC Ophthalmol; 2018 Sep; 18(1):237. PubMed ID: 30185156
[TBL] [Abstract][Full Text] [Related]
19. Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye.
Cui L; Li Y; Lee HS; Yang JM; Choi W; Yoon KC
Int Ophthalmol; 2018 Oct; 38(5):2021-2030. PubMed ID: 28822028
[TBL] [Abstract][Full Text] [Related]
20. Randomized Comparison Between Rebamipide Ophthalmic Suspension and Diquafosol Ophthalmic Solution for Dry Eye After Penetrating Keratoplasty.
Kobashi H; Kamiya K; Shimizu K
J Ocul Pharmacol Ther; 2017; 33(1):13-18. PubMed ID: 27937084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
